Taysha Gene Therapies
TSHA
#5326
Rank
ยฃ1.21 B
Marketcap
ยฃ4.23
Share price
-0.18%
Change (1 day)
118.54%
Change (1 year)

Revenue for Taysha Gene Therapies (TSHA)

Revenue in 2026 (TTM): ยฃ5.51 Million

According to Taysha Gene Therapies's latest financial reports the company's current revenue (TTM ) is ยฃ5.58 Million. In 2025 the company made a revenue of ยฃ7.25 Million an increase over the revenue in the year 2024 that were of ยฃ6.64 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taysha Gene Therapies from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ5.51 M-23.94%
2025 ยฃ7.25 M9.29%
2024 ยฃ6.64 M-45.25%
2023 ยฃ12.12 M486.43%
2022 ยฃ2.06 M
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA